Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Healthcare provision

Life-saving drugs continue to be excluded from Syrian humanitarian aid convoys

The Syrian government continues to exclude life-saving drugs from international humanitarian aid convoys destined for opposition held areas and is ignoring calls by United Nations (UN) officials for unimpeded access.

Items excluded or removed from convoys have gone beyond trauma and surgical items, and have included life-saving and life-sustaining medicines, according to the World Health Organization (WHO) and other UN relief agencies.

UN officials estimate that between January 2016 and March 2016 exclusions resulted in 80,000 people being denied life-saving medical treatments.

Tarik Jasarevic, a spokesperson for the WHO, said that a number of health items were removed from a convoy to Kafr Batna in Eastern Ghouta on 16 April 2016. “The items included 1 burn kit, 1,000 diazepam, 5,000 paracetamol tablets, 5,000 bottles of multivitamins and 5,000 tubes of sodium fusidate ointment. From a total list of 57 medical items 7 were removed.” Atropine, haloperidol, phenobarbitone and sodium valproate were removed from another convoy, destined for Afrin in Aleppo, he added.

Steffan de Mistura, the UN Special Envoy for Syria, who is chairing peace talks between the sides in the five-year civil war, has raised concerns over medical supplies with Syrian authorities. “They assured me that they were going to henceforth allow all medical items, except the following: surgical items, atropine and anxiety pills.”

The WHO estimates that 1 in 30 Syrians is suffering from a severe mental health condition, such as severe depression, psychosis or a disabling form of anxiety, and that at least 1 in 5 Syrians is suffering from a mild to moderate mental health condition or anxiety disorder.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201041

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £535.00Buy now
  • Injectable Drugs Guide

    Injectable Drugs Guide

    A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.

    £54.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Steffan de Mistura, UN Special Envoy for Syria

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.